骨髓灰质炎:不断变化的治疗景观
Gil I Wolfe1, Jonathan E Hanson1, Nicholas J Silvestri1
1From the Dept. of Neurology, Jacobs School of Medicine and Biomedical Sciences, Univ. at Buffalo, State University of New York, Buffalo, NY, USA.
eNeurologicalSci
|December 9, 2024
概括
最近的进展为一般化骨髓灰质炎 (gMG) 提供了新的药理疗法. 像补充抑制剂和新生儿Fc受体对抗剂这样的新疗法显示出长期的有效性,并在gMG管理中减少类固醇依赖.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 一般化肌痛性肌痛症 (gMG) 是一种慢性自身免疫神经肌肉疾病.
- 在历史上,对gMG的治疗选择有限,通常依赖于皮质类固醇.
- 近年来,对gMG的治疗策略有显著的扩张.
研究的目的:
- 总结一下最近在一般化肌痛性骨髓炎 (gMG) 管理方面的药理学进展.
- 概述新型GMG疗法的当前和潜在的未来使用情况.
- 要突出第3阶段研究和开放标签扩展的关键发现.
主要方法:
- 对新型GMG疗法的最新临床试验数据的审查.
- 从开放标签扩展研究中分析长期疗效和安全性.
- 关于补充剂抑制剂和新生儿Fc受体抗剂的信息综合.
主要成果:
- 现在有几种新的药理学药物,包括补充抑制剂和新生儿Fc受体对抗剂,可用于gMG.
- 第三阶段研究和随后的开放式扩展表明这些药物的长期有效性.
- 观察到的好处包括显著减少对皮质类固醇治疗的需要.
结论:
- 由于新的治疗方案,GMG的药理景观已经发生了变化.
- 这些新疗法提供持续的疗效和改善患者的治疗结果.
- 未来的GMG管理可能需要增加这些先进的药理学剂的使用.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Myasthenia Gravis: Diagnostic Tests
644
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
644
Disorders of the Skeletal Muscle
876
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
876
Cholinergic Antagonists: Therapeutic Uses
713
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
713
Chemical Synapses
8.7K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.7K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
689
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
689


